Literature DB >> 22761298

Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species.

Michel S Zygmunt1, Isabelle Jacques, Nelly Bernardet, Axel Cloeckaert.   

Abstract

Recently, novel Brucella strains with phenotypic characteristics that were atypical for strains belonging to the genus Brucella have been reported. Phenotypically many of these strains were initially misidentified as Ochrobactrum spp. Two novel species have been described so far for these strains, i.e., B. microti and B. inopinata, and other strains genetically related to B. inopinata may constitute other novel species as well. In this study, we analyzed the lipopolysaccharides (LPS) (smooth LPS [S-LPS] and rough LPS [R-LPS]) of these atypical strains using different methods and a panel of monoclonal antibodies (MAbs) directed against several epitopes of the Brucella O-polysaccharide (O-PS) and R-LPS. Among the most striking results, Brucella sp. strain BO2, isolated from a patient with chronic destructive pneumonia, showed a completely distinct S-LPS profile in silver stain gels that looked more similar to that of enterobacterial S-LPS. This strain also failed to react with MAbs against Brucella O-PS epitopes and showed weak reactivity with anti-R-LPS MAbs. B. inopinata reference strain BO1 displayed an M-dominant S-LPS type with some heterogeneity relative to the classical M-dominant Brucella S-LPS type. Australian wild rodent strains belonging also to the B. inopinata group showed a classical A-dominant S-LPS but lacked the O-PS common (C) epitopes, as previously reported for B. suis biovar 2 strains. Interestingly, some strains also failed to react with anti-R-LPS MAbs, such as the B. microti reference strain and B. inopinata BO1, suggesting modifications in the core-lipid A moieties of these strains. These results have several implications for serological typing and serological diagnosis and underline the need for novel tools for detection and correct identification of such novel emerging Brucella spp.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761298      PMCID: PMC3428386          DOI: 10.1128/CVI.00300-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

Review 1.  Brucella evolution and taxonomy.

Authors:  Edgardo Moreno; Axel Cloeckaert; Ignacio Moriyón
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.

Authors:  E Giraud; A Cloeckaert; D Kerboeuf; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 3.  Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century.

Authors:  J Godfroid; H C Scholz; T Barbier; C Nicolas; P Wattiau; D Fretin; A M Whatmore; A Cloeckaert; J M Blasco; I Moriyon; C Saegerman; J B Muma; S Al Dahouk; H Neubauer; J-J Letesson
Journal:  Prev Vet Med       Date:  2011-05-14       Impact factor: 2.670

4.  Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis.

Authors:  J Limet; A M Plommet; G Dubray; M Plommet
Journal:  Ann Inst Pasteur Immunol       Date:  1987 May-Jun

5.  Fine structure of A and M antigens from Brucella biovars.

Authors:  P J Meikle; M B Perry; J W Cherwonogrodzky; D R Bundle
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides.

Authors:  D R Bundle; J W Cherwonogrodzky; M A Gidney; P J Meikle; M B Perry; T Peters
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

7.  Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies.

Authors:  D R Bundle; M A Gidney; M B Perry; J R Duncan; J W Cherwonogrodzky
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Evidence of heterogeneity of lipopolysaccharides among Brucella biovars in relation to A and M specificities.

Authors:  G Dubray; J Limet
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

9.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

10.  Use of monoclonal antibodies to identify the distribution of A and M epitopes on smooth Brucella species.

Authors:  J T Douglas; D A Palmer
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more
  20 in total

1.  Thermostable cross-protective subunit vaccine against Brucella species.

Authors:  John W Cherwonogrodzky; Nicole D Barabé; Michelle L Grigat; William E Lee; Robert T Poirier; Scott J Jager; Bradley J Berger
Journal:  Clin Vaccine Immunol       Date:  2014-10-15

2.  Transcriptome-Wide Identification of Hfq-Associated RNAs in Brucella suis by Deep Sequencing.

Authors:  Bashir Saadeh; Clayton C Caswell; Yanjie Chao; Philippe Berta; Alice Rebecca Wattam; R Martin Roop; David O'Callaghan
Journal:  J Bacteriol       Date:  2015-11-09       Impact factor: 3.490

3.  Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.

Authors:  Alice R Wattam; Thomas J Inzana; Kelly P Williams; Shrinivasrao P Mane; Maulik Shukla; Nalvo F Almeida; Allan W Dickerman; Steven Mason; Ignacio Moriyón; David O'Callaghan; Adrian M Whatmore; Bruno W Sobral; Rebekah V Tiller; Alex R Hoffmaster; Michael A Frace; Cristina De Castro; Antonio Molinaro; Stephen M Boyle; Barun K De; João C Setubal
Journal:  MBio       Date:  2012-08-28       Impact factor: 7.867

4.  Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species.

Authors:  Angelika Silbereisen; Marco Tamborrini; Matthias Wittwer; Nadia Schürch; Gerd Pluschke
Journal:  BMC Microbiol       Date:  2015-10-05       Impact factor: 3.605

5.  Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice.

Authors:  Pedro Soler-Lloréns; Yolanda Gil-Ramírez; Ana Zabalza-Baranguá; Maite Iriarte; Raquel Conde-Álvarez; Amaia Zúñiga-Ripa; Beatriz San Román; Michel S Zygmunt; Nieves Vizcaíno; Axel Cloeckaert; María-Jesús Grilló; Ignacio Moriyón; Ignacio López-Goñi
Journal:  Vet Res       Date:  2014-07-17       Impact factor: 3.683

6.  A Brucella spp. Isolate from a Pac-Man Frog (Ceratophrys ornata) Reveals Characteristics Departing from Classical Brucellae.

Authors:  Pedro F Soler-Lloréns; Chris R Quance; Sara D Lawhon; Tod P Stuber; John F Edwards; Thomas A Ficht; Suelee Robbe-Austerman; David O'Callaghan; Anne Keriel
Journal:  Front Cell Infect Microbiol       Date:  2016-09-28       Impact factor: 5.293

Review 7.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

Review 8.  When the Going Gets Rough: The Significance of Brucella Lipopolysaccharide Phenotype in Host-Pathogen Interactions.

Authors:  Lauren W Stranahan; Angela M Arenas-Gamboa
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

9.  The epitopic and structural characterization of Brucella suis biovar 2 O-polysaccharide demonstrates the existence of a new M-negative C-negative smooth Brucella serovar.

Authors:  Mona V Zaccheus; Tara Ali; Axel Cloeckaert; Michel S Zygmunt; Andrej Weintraub; Maite Iriarte; Ignacio Moriyón; Göran Widmalm
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Smooth to Rough Dissociation in Brucella: The Missing Link to Virulence.

Authors:  Marcos Mancilla
Journal:  Front Cell Infect Microbiol       Date:  2016-01-05       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.